Human Mycobacterium bovis infection and bovine tuberculosis outbreak, Michigan, 1994-2007.
Historically, Mycobacterium bovis infection in humans .was associated with consumption of unpasteurized milk and dairy products (1,2) and this is still the most important route of exposure in developing countries. US populations are exposed to unpasteurized dairy products imported from countries where M. bovis is prevalent (3,4). M. bovis infection in humans is of concern to health officials in Michigan because of to its endemicity in the state's wild white-tailed deer population and its discovery in several cattle herds. M. bovis in deer represents possible occupational and recreational routes of exposure to humans, especially for hunters, trappers, taxidermists, venison processors, and venison consumers (5).
Although M. bovis is a zoonotic agent, surveillance indicates no increase in its incidence in Michigan residents since an outbreak began in 1994. Since 1995, the incidence rate of M. bovis infection in Michigan residents has remained very low, with [approximately equal to] 1 new case per year for a total of 13. No genetic or epidemiologic link to the deer/cattle outbreak strain has been identified among 11 of these human M. bovis cases, based on restriction fragment-length polymorphism analysis, spoligotyping, or mycobacterial interspersed repeat units (MIRU) typing (M. Wilkins, unpub. data, Michigan Department of Community Health, March 2007). Table 1 shows the spoligotyping and MIRU typing results from 9 available human specimens that were unrelated to the deer/cattle outbreak strain. All genotyping of isolates mentioned in this report was performed at the Michigan Department of Community Health, Bureau of Laboratories, Lansing, MI, USA, by using currently recommended guidelines (Centers for Disease Control and Prevention, Atlanta, GA, USA) (8-10). The remaining 2 human cases of M. bovis occurred in US-born, Michigan residents; the cases had epidemiologic and molecular links to the genotypically consistent deer/cattle outbreak strain circulating in Michigan.
Patient 1, 2002
In January 2002, a 74-year-old man sought medical care, reporting malaise, anorexia, and fever. Past medical history included ischemic bowel disease, vascular disease, partial gastrectomy for peptic ulcers, and left upper lobectomy for squamous cell carcinoma (December 1999). On February 1, he was hospitalized with persistent fever and nonproductive cough; results of a chest radiograph were consistent with necrotizing pneumonia. A tuberculosis (TB) skin test (TST) result was negative, and a sputum smear was negative for acid-fast bacilli (AFB). After 5 days, the patient had not improved clinically; chest radiograph showed increasing infiltrate on the left side. Diagnostic bronchoscopy was performed, which yielded an AFB-positive smear. The condition of the patient deteriorated clinically over the next 10 days; he died on day 16 of his hospitalization.
Laboratory confirmation for TB, speciation, and antimicrobial drug susceptibility testing were pending at the time of his death. Genotyping analysis showed that the M. bovis isolated from this patient matched the circulating deer/cattle strain (Table 2).
In his youth, patient 1 lived on a farm geographically distant from the current bovine TB-endemic area. His first wife had a reported diagnosis of TB after their divorce >40 years before, and his second wife reports he drank unpasteurized milk as a youth. He moved to the edge of Deer Management Unit (DMU) 452 in 1994, which is the focal area for the bovine TB outbreak in deer. There, he ran a business with a buck pole where hunters displayed killed deer. Additional potential exposures included hunting white-tailed deer and consuming venison (> 10 years before his death), handling a deer carcass from the DMU 452 vicinity in 2000, and recreational feeding of deer.
This patient was in poor health at the time of death, having acute and chronic illness. His poor health would have rendered him more susceptible to infection with M. bovis and would have made the progression from latent infection to clinical disease more likely. The pathology results from his lung resection in December 1999 provided no evidence of TB; therefore, infection was likely acquired subsequently. The genotyping results from patient 1 matched those of the circulating deer/cattle strain, which suggested exposure to infected cattle or deer. The lack of recent exposure to cattle suggests that deer are the more likely source of infection.
Patient 2, 2004
Patient 2 was a 29-year-old, previously healthy man. On October 1, 2004, he shot a white-tailed deer just outside DMU 452. While field dressing the animal, he punctured his left index finger with a hunting knife. Approximately 18 days after the injury, his finger became inflamed and painful, so he sought medical treatment. Based on his history of exposure to a deer with lesions, a TST was administered; the result was negative. After [approximately equal to] 10 days of antimicrobial drug therapy, the wound had not improved. He was hospitalized, and the infected finger was incised and drained. An orthopedic specialist diagnosed infectious tenosynovitis of the flexor tendon of the left index finger. The initial slide preparation was negative for AFB. A wound culture was sent to Michigan Department of Community Health, Bureau of Laboratories.
The patient was discharged and then readmitted to the hospital 12 days later with subcutaneous infection at the puncture site, which was again incised and drained. A slide made of growth from the broth culture medium was positive for AFB. Genetic probe results confirmed M. tuberculosis complex. By December 7, 2004, the culture was reported as resistant to pyrazinamide, suggesting M. bovis, which was later confirmed on the basis of susceptibility to thiopene-2-carboxylic acid hydrazide and biochemical testing for pyrazinamidase. The result of a second skin test, 14 weeks postexposure, was positive (6-mm induration). He continued to receive antimicrobial drug therapy for 9 months without further complications
As an experienced hunter, patient 2 recognized the tan nodules in the deer's chest cavity as M. boris and promptly buried the carcass. In December, he led Michigan Department of Natural Resources staff back to the carcass, which was retrieved; the chest cavity was filled with lesions (Figure). Although the carcass was buried for >9 weeks, chest cavity samples were submitted for culture. After numerous attempts with alternative decontamination techniques, a viable culture was obtained. Genotyping results of the carcass isolate were identical to that recovered from patient 2 and the circulating deer/cattle strain (Table 2). The investigation of the infection in patient 2 provided strong evidence of transmission of M. boris infection from deer to human through percutaneous injection with a contaminated hunting knife. The patient's history of hunting exposure was essential to diagnosis and treatment of this rare form of TB.
Although epidemiologic evidence presented for patient 1 is not irrefutable, we conclude that both cases are part of a cluster that is epidemiologically and genotypically confirmed (11). The initial TST result was negative in both of these cases, likely due to cutaneous anergy (patient 1) and administration too soon after exposure (patient 2). Initial negative skin test results made diagnosis problematic for healthcare providers.
The confirmation of a hunter's acquiring cutaneous M. bovis from an infected deer supports the need for public health precautions. First, hunters should wear heavy latex or rubber gloves while field dressing deer. Second, hunter education was important in the second case because the hunter recognized the deer as infected and specifically mentioned his exposure each time he sought medical treatment. Third, efforts to raise the index of suspicion of the medical community regarding cutaneous and other occupational or recreational exposures to TB continues to be important, so that appropriate diagnoses can be made. Finally, in both cases, the initially negative TST result complicated the diagnostic efforts. It is an ongoing challenge to ensure that providers appropriately apply and interpret the TST.
We thank Sue Lovelace and Bridget Patrick for patient 2 follow-up, Steven V. Church for his laboratory contributions, and Dan J. O'Brien and Steven M. Schmitt for Michigan Department of Natural Resources assistance.
Dr Wilkins is the director of the Division of Communicable Disease, Michigan Department of Community Health. Her research interests include the epidemiology and control of zoonotic diseases, specifically M. boris, and surveillance system development and evaluation. She is also a doctoral candidate at Michigan State University, College of Veterinary Medicine.
(1.) Enarson DA, Rieder HL, Meslin FX, Cosivi O. The importance of Mycobacterium boris to the tuberculosis epidemic in humans. In: Thoen CO, Steel JH, editors. Mycobacterium boris: infection in animals and humans. Ames (IA): Iowa State University Press; 2006. p. xxii-xxv.
(2.) Wigle WD, Ashley MJ, Killough EM, Cosens M. Bovine tuberculosis in humans in Ontario: the epidemiologic features of 31 active cases occurring between 1964 and 1970. Am Rev Respir Dis. 1972;106:528-34.
(3.) Dankner WM, Waecker NJ, Essey MA, Moser K, Thompson M, Davis CE. Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine (Baltimore). 1993;72:11-37.
(4.) Centers for Disease Control and Prevention. Human tuberculosis caused by Mycobacterium bovis--New York City, 2001-2004. MMWR Morb Mortal Wkly Rep. 2005;54:605-8.
(5.) Wilkins MJ, Bartlett PC, Frawley B, O'Brien DJ, Miller CE, Boulton ML. Mycobacterium boris (bovine TB) exposure as a recreational risk for hunters: results of a Michigan Hunter Survey, 2001. Int J Tuberc Lung Dis. 2003;7:1001-9.
(6.) Cowan LS, Mosher L, Diem L, Massey JP, Crawford JT. Variable-number tandem repeat typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110 by using mycobacterial interspersed repetitive units. J Clin Microbiol. 2002;40:1592-602.
(7.) Mycobacterium bovis international database [cited 2007 Mar 14]. Available from http://www.mbovis.org
(8.) Yang Z, Barnes PF, Chaves F, Eisenach KD, Weis SE, Bates JH, et al. Diversity of DNA fingerprints of Mycobacterium tuberculosis isolates in the United States. J Clin Microbiol. 1998;36:1003-7.
(9.) Cowan LS, Diem L, Brake MC, Crawford JT. Transfer of a Mycobacterium tuberculosis genotyping method, spoligotyping, from a reverse line-blot hybridization, membrane-based assay to the Luminex multianalyte profiling system. J Clin Microbiol. 2004;42:474-7.
(10.) Kwara A, Schiro R, Cowan LS, Hyslop NE, Wiser MF, Harrison SR, et al. Evaluation of the epidemiologic utility of secondary typing methods for differentiation of Mycobacterium tuberculosis isolates. J Clin Microbiol. 2003:41:2683-5.
(11.) National TB. Controllers Association/CDC Advisory, Group on Tuberculosis Genotyping. Guide to the application of genotyping to tuberculosis prevention and control. Atlanta: Centers for Disease Control and Prevention; June 2004 [cited 2007 Mar 14]. Available from http://www.cdc.gov/nchstp/tb/genotyping/toc.htm
Address for correspondence: Melinda J. Wilkins, Michigan Department of Community Health, 201 Townsend, PO Box 30195, Lansing, MI, 48909: email: firstname.lastname@example.org
Melinda J. Wilkins, * Joshua Meyerson, ([dagger]) Paul C. Bartlett, ([double dagger]) Susan L. Spieldenner, * Dale E. Berry, * Laura B. Mosher, * John B. Kaneene, ([double dagger]) Barbara Robinson-Dunn,([section]) Mary Grace Stobierski, * Matthew L. Boulton ([paragraph])
* Michigan Department of Community Health, Lansing, Michigan, USA; ([dagger]) Health Department of Northwest Michigan, Charlevoix, Michigan, USA; ([double dagger]) Michigan State University, East Lansing, Michigan, USA; ([section]) Beaumont Hospital, Royal Oak, Michigan, USA; and ([paragraph]) University of Michigan, Ann Arbor, Michigan, USA
Table 1. Nonepidemiologically linked human Mycobacterium bovis spoligotyping and MIRU typing results for 9 available human specimens, Michigan * International Country Year spoligotype of birth Site collected ([dagger]) USA Cervical 1997 SB1210 LN USA Spine 1997 SB0131 Mexico Abd 1998 SB0140 abscess Mexico Sputum 1998 SB1210 Bosnia Cervical 2000 SB1215 LN Mexico Sputum 2003 SB0121 USA Cervical 2003 SB0121 LN Mexico Cervical 2005 SB1216 LN Mexico Cervical 2007 SB0140 LN Country of birth MIRU type Spoligotypes USA Not available [??] USA Not available [??] Mexico 232224152322 [??] Mexico Not available [??] Bosnia 232314353312 [??] Mexico 232314223322 [??] USA 232324252322 [??] Mexico 232124233222 [??] Mexico 231224243322 [??] * MIRU, mycobacterial interspersed repeat units (6), LN, lymph node; Abd, abdominal. ([dagger]) International Spoligotype Database, available from www.mbovis.org (7). Table 2. Epidemiologically linked Mycobacterium bovis spoligotyping and MIRU typing results, Michigan' International Year spoligotype Species collected ([dagger]) MIRU type Deer 1 1997 SB0145 Not available Bovine 1 1998 SB0145 Not available Bovine 2 1999 SB0145 232224253322 Bovine 3 1999 SB0145 232224253322 Bovine 4 2002 SB0145 232224253322 Human patient 1 2002 SB0145 232224253322 Deer 2 2003 SB0145 232224253322 Human patient 2 2004 SB0145 232224253322 Deer 3 ([double dagger]) 2004 SB0145 232224253322 Species Spoligotypes Deer 1 [??] Bovine 1 [??] Bovine 2 [??] Bovine 3 [??] Bovine 4 [??] Human patient 1 [??] Deer 2 [??] Human patient 2 [??] Deer 3 ([double dagger]) [??] * MIRU, mycobacterial interspersed repeat units (6). ([dagger]) International Spoligotype Database, available from www.mbovis.org (7). ([double dagger]) Deer shot by patient 2.
|Printer friendly Cite/link Email Feedback|
|Author:||Wilkins, Melinda J.; Meyerson, Joshua; Bartlett, Paul C.; Spieldenner, Susan L.; Berry, Dale E.; Mos|
|Publication:||Emerging Infectious Diseases|
|Date:||Apr 1, 2008|
|Previous Article:||Single nucleotide polymorphism typing of Bacillus anthracis from Sverdlovsk tissue.|
|Next Article:||Mycobacterium avium lymphadenopathy among children, Sweden.|